Undervalued Stocks Based on Data Mining: Returns up to 18.57% in 14 Days

Undervalued Stocks

The Medicine Stocks Package is designed for investors and analysts who need predictions for the best stocks to buy in the Medicine Industry. It includes 20 stocks with bullish and bearish signals and indicates the best medicine stocks to trade:

  • Top 10 Medicine stocks for the long position
  • Top 10 Medicine stocks for the short position

Package Name: Medicine Stocks
Recommended Positions: Long
Forecast Length: 14 Days (06/07/2017 – 06/21/2017)
I Know First Average: 4.86%
Undervalued Stocks

For this 14 Days forecast the algorithm had successfully predicted 7 out of 10 movements. The highest trade return came from ALNY, at 18.57%. The suggested trades for FOLD and REGN also had notable 14 Days yields of 16.80% and 9.27%, respectively. The overall average return in this Medicine Stocks package was 4.86%, providing investors with a 4.60% premium over the S&P 500’s return of 0.26% during the same period.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference. Its pipeline of investigational RNAi therapeutics is focused on genetic medicines, cardio-metabolic diseases, and hepatic infectious diseases.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.